Haichun Liu Selected Research

Haichun Liu Research Topics

Disease

9	Neoplasms (Cancer) 05/2022 - 04/2011
5	Osteoporosis 01/2021 - 02/2018
3	Osteosarcoma (Osteogenic Sarcoma) 04/2018 - 01/2015
2	Schizophrenia (Dementia Praecox) 01/2022 - 01/2020
2	Psychotic Disorders (Schizoaffective Disorder) 01/2022 - 01/2022
2	Thrombosis (Thrombus) 01/2021 - 10/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020 - 07/2013
2	Inflammation (Inflammations) 09/2018 - 05/2018
2	Neoplasm Metastasis (Metastasis) 04/2018 - 07/2013
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2012 - 03/2011
1	COVID-19 04/2022
1	Flushing 01/2022
1	Pathologic Constriction (Stenosis) 10/2020
1	Venous Thromboembolism 10/2020
1	Spondylolisthesis 10/2020
1	Alcoholic Fatty Liver 09/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 06/2020
1	Femoral Fractures (Femoral Fracture) 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020
1	Erythema 01/2020
1	Discitis 12/2019
1	Bone Diseases (Bone Disease) 08/2019
1	Hypoxia (Hypoxemia) 09/2018
1	Neuroinflammatory Diseases 09/2018
1	Osteoarthritis 05/2018
1	Adenocarcinoma of Lung 04/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Myocardial Infarction 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Peripheral Nerve Injuries 01/2017
1	Liver Neoplasms (Liver Cancer) 09/2014
1	Hepatocellular Carcinoma (Hepatoma) 09/2014
1	Type 2 Diabetes Mellitus (MODY) 02/2014
1	Lung Neoplasms (Lung Cancer) 07/2013

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 05/2022 - 04/2011
2	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2022 - 01/2022
2	Tranexamic Acid (AMCA)FDA Link 01/2021 - 10/2020
2	RivaroxabanIBA 01/2021 - 10/2020
1	ThuliumIBA 05/2021
1	MAP Kinase Kinase Kinase 5IBA 09/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2020
1	motesanib diphosphateIBA 06/2020
1	AminesIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	fms-Like Tyrosine Kinase 3IBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	Drug CarriersIBA 12/2019
1	LactonesIBA 12/2019
1	SiliconIBA 08/2019
1	Trace Elements (Biometals)IBA 08/2019
1	CytokinesIBA 09/2018
1	Glucose (Dextrose)FDA LinkGeneric 09/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2018
1	acetylpuerarinIBA 09/2018
1	Oxygen (Dioxygen)IBA 09/2018
1	Matrix Metalloproteinases (MMPs)IBA 05/2018
1	3-methyladenineIBA 05/2018
1	ResveratrolIBA 05/2018
1	Metalloproteases (Metalloproteinases)IBA 05/2018
1	CateninsIBA 05/2018
1	Long Noncoding RNAIBA 04/2018
1	ferric ammonium citrate FDA Link 02/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Thrombin FDA Link 01/2018
1	LigandsIBA 01/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	Biological ProductsIBA 01/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	OsteocalcinIBA 10/2016
1	Transcription Factors (Transcription Factor)IBA 10/2016
1	AcidsIBA 10/2016
1	Collagen Type I (Type I Collagen)IBA 10/2016
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Immunoconjugates (Immunoconjugate)IBA 09/2014
1	metuximabIBA 09/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 02/2014
1	Nonesterified Fatty Acids (NEFA)IBA 02/2014
1	OsteopontinIBA 07/2013
1	Carbolines (Beta-Carbolines)IBA 07/2012
1	AlkaloidsIBA 07/2012

Therapy/Procedure

2	Ovariectomy (Oophorectomy) 01/2021 - 07/2019
2	Therapeutics 01/2015 - 07/2012
2	Transplantation 10/2012 - 03/2011
1	Oral Administration 01/2020
1	Radiofrequency Ablation 09/2014